MMJ International Investments' Acquisition

MMJ International Investments was acquired by Scythian Biosciences on May 16, 2018.

MMJ International Investments (MMJIH) aims to be a leader in prescription cannabinoid medicines, developing and commercializing pharmaceutical products which addresses patients unmet medical needs.…

Articles about MMJ International Investments' Acquisition: